Formulation, Characterization, and Stability of Protein Drugs : Case Histories - Pearlman, Rodney; Wang, Y. John.; SpringerLink (Online service) (New York, NY : Springer US : Imprint: Springer, 2002)
A Compendium and Hydropathy/ Flexibility Analysis of Common Reactive Sites in Proteins: Reactivity at Asn, Asp, Gin, and Met Motifs in Neutral pH Solution -- Characterization, Stability, and Formulations of Basic Fibroblast Growth Factor -- The Characterization, Stabilization, and Formulation of Acidic Fibroblast Growth Factor -- Stability, Characterization, Formulation, and Delivery System Development for Transforming Growth Factor-Beta1 -- Stability and Characterization of Recombinant Human Relaxin -- Interferon-?-1b (Betaseron®): A Model for Hydrophobic Therapeutic Proteins -- Characterization, Formulation, and Stability of Neupogen® (Filgrastim), a Recombinant Human Granulocyte-Colony Stimulating Factor -- Development and Shelf-Life Determination of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (LEUKINE®, GM-CSF) -- Formulation Development of an Antifibrin Monoclonal Antibody Radiopharmaceutical -- Biophysical Characterization and Formulation of TP40: A Chimeric Protein that Requires a pH-Dependent Conformational Change for Its Biological Activity -- Stability Characterization and Formulation Development of Recombinant Human Deoxyribonuclease I [Pulmozyme®, (Dornase Alpha)].
Keywords: Pharmacology; Pharmacy; Pharmacology/Toxicology.; Pharmacy